CoChat
Sign Up
Cited by 34

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Development and characterization of P-glycoprotein 1 (Pgp1, ABCB1)-mediated doxorubicin-resistant PLHC-1 hepatoma fish cell line

Zaja, Roko, Caminada, Daniel, Lončar, Jovica, Fent, Karl, Smital, Tvrtko·2008·Toxicology and Applied Pharmacology
DOI 10.1016/j.taap.2007.11.001
Open this paper in CoChat — free account

Abstract

The development of the multidrug resistance (MDR) phenotype in mammals is often mediated by the overexpression of the P-glycoprotein1 (Pgp, ABCB1) or multidrug resistance-associated protein (MRP)-like ABC transport proteins. A similar phenomenon has also been observed and considered as an important part of the multixenobiotic resistance (MXR) defence system in aquatic organisms. We have recently demonstrated the presence of ABC transporters in the widely used in vitro fish model, the PLHC-1 hepatoma cell line. In the present study we were able to select a highly resistant PLHC-1 sub-clone (PLHC-1/dox) by culturing the wild-type cells in the presence of 1 microM doxorubicin. Using quantitative PCR a 42-fold higher expression of ABCB1 gene was determined in the PLHC-1/dox cells compared to non-selected wild-type cells (PLHC-1/wt). The efflux rates of model fluorescent Pgp1 substrates rhodamine 123 and calcein-AM were 3- to 4-fold higher in the PLHC-1/dox in comparison to the PLHC-1/wt cells. PLHC-1/dox were 45-fold more resistant to doxorubicin cytotoxicity than PLHC-1/wt. Similarly to mammalian cell lines, typical cross-resistance to cytotoxicity of other chemotherapeutics such as daunorubicin, vincristine, vinblastine, etoposide and colchicine, occurred. Furthermore, cyclosporine A, verapamil and PSC833, specific inhibitors of Pgp1 transport activity, completely reversed resistance of PLHC-1/dox cells to all tested drugs, resulting in EC50 values similar to the EC50 values fo…

Overview

Integrity signals

Registry

Crossref · 10.1016/j.taap.2007.11.001

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 1 references

Research works printed but not linked: 55

  1. Ades, 2005, Selection of non-P-glycoprotein mediated high-level etoposide resistant cell lines by adriamycin with P-gp inhibitors, Int. J. Oncol., 27, 747
  2. Arora, 2004, Reversal of P-glycoprotein-mediated multidrug resistance by diallyl sulphide in K562 leukemic cells and in mouse liver, Carcinogenesis, 25, 941, 10.1093/carcin/bgh060 · DOI
  3. Babich, 1991, In vitro cytotoxicity studies with the fish hepatoma cell line, PLHC-1 (Poeciliopsis lucida), Ecotoxicol. Environ. Saf., 21, 327, 10.1016/0147-6513(91)90072-W · DOI
  4. Bai, 2004, Multidrug resistance protein 4 (MRP4/ABCC4) mediates efflux of bimane–glutathione, Int. J. Biochem. Cell Biol., 36, 247, 10.1016/S1357-2725(03)00236-X · DOI
  5. Bard, 2000, Multixenobiotic resistance as a cellular defense mechanism in aquatic organisms, Aquat. Toxicol., 48, 357, 10.1016/S0166-445X(00)00088-6 · DOI
  6. Bohacova, 2006, L1210 cells cultivated under the selection pressure of doxorubicin or vincristine express common mechanisms of multidrug resistance based on the overexpression of P-glycoprotein, Toxicol. In Vitro, 20, 1560, 10.1016/j.tiv.2006.07.011 · DOI
  7. Britvic, 1999, The effect of inhibitors of multixenobiotic resistance mechanism on the production of mutagens by Dreissena polymorpha in waters spiked with premutagens, Aquat. Toxicol., 47, 107, 10.1016/S0166-445X(99)00011-9 · DOI
  8. Cai, 2003, Molecular characterization of a multidrug resistance-associated protein, Mrp2, from the little skate, Am. J. Physiol., Regul. Integr. Comp. Physiol., 284, 125, 10.1152/ajpregu.00392.2002 · DOI
  9. Callaghan, 2006, The translocation mechanism of P-glycoprotein, FEBS Lett., 580, 1056, 10.1016/j.febslet.2005.11.083 · DOI
  10. Caminada, 2006, Cytotoxicity of pharmaceuticals found in aquatic systems: comparison of PLHC-1 and RTG-2 fish cell lines, Aquat. Toxicol., 79, 114, 10.1016/j.aquatox.2006.05.010 · DOI
  11. Chan, 2004, The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability, Eur. J. Pharm. Sci., 21, 25, 10.1016/j.ejps.2003.07.003 · DOI
  12. Chen, 1994, Prevalence of multi drug resistance related to activation of the mdr1 gene in human sarcoma mutants derived by single-step doxorubicin selection, Cancer Res., 54, 4980
  13. Cornwell, 1986, Membrane vesicles from multidrug-resistant human cancer cells contain a specific 150- to 170-kDa protein detected by photoaffinity labeling, Proc. Natl. Acad. Sci. U. S. A., 83, 3847, 10.1073/pnas.83.11.3847 · DOI
  14. Daoud, 2000, Rhodamine 123 binds to multiple sites in the multidrug resistance protein (MRP1), Biochemistry, 39, 15344, 10.1021/bi0020574 · DOI
  15. Deeley, 2006, Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins, Physiol. Rev., 86, 849, 10.1152/physrev.00035.2005 · DOI · Paper page
  16. Dixon, 1994, A novel cDNA restores reduced folate carrier activity and methotrexate sensitivity to transport deficient cells, J. Biol. Chem., 269, 17, 10.1016/S0021-9258(17)42301-5 · DOI
  17. Doyle, 2003, Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2), Oncogene, 22, 7340, 10.1038/sj.onc.1206938 · DOI
  18. Fent, 2001, Fish cell lines as versatile tools in ecotoxicology: assessment of cytotoxicity, cytochrome P4501A induction potential and estrogenic activity of chemicals and environmental samples, Toxicol. Vitro, 15, 477, 10.1016/S0887-2333(01)00053-4 · DOI
  19. Fent, 2000, Cytochrome P4501A induction potencies of polycyclic aromatic hydrocarbons in a fish hepatoma cell line: demonstration of additive interactions, Environ. Toxicol. Chem., 19, 2047, 10.1002/etc.5620190813 · DOI
  20. Gong, 2003, Separate roles for the Golgi apparatus and lysosomes in the sequestration of drugs in the multidrug-resistant human leukemic cell line HL-60, J. Biol. Chem., 278, 50234, 10.1074/jbc.M306606200 · DOI
  21. Habig, 1974, Glutathione S-transferase, the first enzymatic step in mercapturic acid formation, J. Biol. Chem., 249, 7130, 10.1016/S0021-9258(19)42083-8 · DOI
  22. Hahn, 1993, Cytochrome P4501A induction and inhibition by 3,3′,4,4′-tetrachlorobiphenyl in an Ah receptor-containing fish hepatoma cell line (PLHC-1), Aquat. Toxicol., 26, 185, 10.1016/0166-445X(93)90030-5 · DOI
  23. Hahn, 1996, Rapid assessment of induced cytochrome P4501A protein and catalytic activity in fish hepatoma cells grown in multiwell plates — response to TCDD, TCDF, and two planar PCBs, Environ. Toxicol. Chem., 15, 582
  24. Holló, 1996, Transport properties of multidrug resistance-associated protein (MRP) in human tumour cells, FEBS Lett., 383, 99, 10.1016/0014-5793(96)00237-2 · DOI
  25. Ikuta, 2005, Expression of multidrug resistance proteins and accumulation of cisplatin in human non-small cell lung cancer cells, Biol. Pharm. Bull., 28, 707, 10.1248/bpb.28.707 · DOI
  26. Kaufmann, 2003, Alterations in the apoptotic machinery and their potential role in anticancer drug resistance, Oncogene, 22, 7414, 10.1038/sj.onc.1206945 · DOI
  27. Kurelec, 1992, The multixenobiotic resistance mechanisms in aquatic organisms, Crit. Rev. Toxicol., 22, 23, 10.3109/10408449209145320 · DOI
  28. Kurelec, 1989, Distinct glutathione-dependent enzyme activities and a verapamil sensitive binding of xenobiotics in a fresh-water mussel Anodonta cygnea, Biochem. Biophys. Res. Commun., 164, 934, 10.1016/0006-291X(89)91548-9 · DOI
  29. Laemmli, 1970, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature, 227, 680, 10.1038/227680a0 · DOI · Paper page
  30. Latunde-Dada, 2006, Recent advances in mammalian haem transport, Trends Biochem. Sci., 31, 182, 10.1016/j.tibs.2006.01.005 · DOI
  31. Leslie, 2005, Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense, Toxicol. Appl. Pharmacol., 204, 216, 10.1016/j.taap.2004.10.012 · DOI
  32. Litman, 2001, From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance, Cell. Mol. Life Sci., 58, 931, 10.1007/PL00000912 · DOI
  33. Lou, 2007, Targeted therapy for cancer stem cells: the patched pathway and ABC transporters, Oncogene, 26, 1357, 10.1038/sj.onc.1210200 · DOI
  34. Lou, 2003, Chelerythrine stimulates GSH transport by rat Mrp2 (Abcc2) expressed in canine kidney cells, Am. J. Physiol.: Gasterointest. Liver Physiol., 285, G1335, 10.1152/ajpgi.00271.2003 · DOI
  35. Lowry, 1951, Protein measurement with the Folin phenol reagent, J. Biol. Chem., 193, 265, 10.1016/S0021-9258(19)52451-6 · DOI
  36. Materna1, 2005, Protection of platinum–DNA adduct formation and reversal of cisplatin resistance by anti-MRP2 hammerhead ribozymes in human cancer cells, Int. J. Cancer, 115, 393, 10.1002/ijc.20899 · DOI
  37. Minier, 1993, P-glycoprotein expression in Crassostrea gigas and Mytilus edulis in polluted seawater, Comp. Biochem. Physiol., B, 106, 1029, 10.1016/0305-0491(93)90068-G · DOI
  38. Moran, 1999, Roles of folylpoly-γ-glutamate synthetase in therapeutics with tetrahydrofolate antimetabolites: an overview, Semin. Oncol., 26, 24
  39. Mosmann, 1983, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J. Immunol. Methods, 65, 55, 10.1016/0022-1759(83)90303-4 · DOI · Paper page
  40. Nakatani, 2005, Establishment and gene analysis, of a cisplatin-resistant cell line, Sa-3R, derived from oral squamous cell carcinoma, Oncol. Rep., 13, 709
  41. Pang, 2005, Karyotipic imbalances and differential gene expressions in acquired doxorubicin resistance of hepatocellular carcinoma cells, Lab. Invest., 85, 664, 10.1038/labinvest.3700254 · DOI
  42. Rau, 2004, Differential susceptibility of fish and rat liver cells to oxidative stress and cytotoxicity upon exposure to prooxidants, Comp. Biochem. Physiol., Part C Pharmacol. Toxicol., 137, 335, 10.1016/j.cca.2004.03.001 · DOI
  43. Ricardo, 2006, Multidrug resistance: retrospect and prospects in anti-cancer drug treatment, Curr. Med. Chem., 13, 1859, 10.2174/092986706777585077 · DOI
  44. Sauerborn, 2004, Identification of multidrug resistance-associated protein (mrp) related gene in red mullet (Mullus barbatus), Mar. Environ. Res., 58, 199, 10.1016/j.marenvres.2004.03.120 · DOI
  45. Schlenk, 1998, Effect of zinc and cadmium treatment on hydrogen peroxide-induced mortality and expression of glutathione and metallothionein in a teleost hepatoma cell line, Aquat. Toxicol., 43, 121, 10.1016/S0166-445X(98)00050-2 · DOI
  46. Smital, 1998, The chemosensitizers of multixenobiotic resistance mechanism in aquatic invertebrates: a new class of pollutants, Mutat. Res., 399, 43, 10.1016/S0027-5107(97)00265-0 · DOI
  47. Smital, 2003, Inducibility of the P-glycoprotein transport activity in the marine mussel Mytilus galloprovincialis and the freshwater mussel Dreissena polymorpha, Aquat. Toxicol., 65, 443, 10.1016/S0166-445X(03)00175-9 · DOI
  48. Smital, 2004, Emerging contaminants — pesticides, PPCPs, microbial degradation products and natural substances as inhibitors of multixenobiotic defense in aquatic organisms, Mutat. Res., 552, 101, 10.1016/j.mrfmmm.2004.06.006 · DOI
  49. Takano, 2001, Analyses by comparative genomic hybridization of genes relating with cisplatin-resistance in ovarian cancer, Hum. Cell, 14, 267
  50. Turton, 2001, Gene expression and amplification in breast carcinoma cells with intrinsic and acquired doxorubicin resistance, Oncogene, 20, 1300, 10.1038/sj.onc.1204235 · DOI
  51. Tutundjian, 2002, Genetic and immunological characterisation of multixenobiotic resistance system in the turbot (Scophthalamus maximus), Comp. Biochem. Physiol., Part B Biochem. Mol. Biol., 132, 463, 10.1016/S1096-4959(02)00058-1 · DOI
  52. Williams, 2003, A DNA expression array to detect toxic stress response in European flounder (Platichthys flesus), Aquat. Toxicol., 65, 141, 10.1016/S0166-445X(03)00119-X · DOI
  53. Žaja, 2006, Detection and functional characterization of Pgp1 (ABCB1) and MRP3 (ABCC3) efflux transporters in the PLHC-1 fish hepatoma cell line, Aquat. Toxicol., 81, 365, 10.1016/j.aquatox.2006.12.015 · DOI
  54. Zelcer, 2001, Characterization of drug transport by the human multidrug resistance protein 3 (ABCC3), J. Biol. Chem., 276, 46400, 10.1074/jbc.M107041200 · DOI
  55. Zeng, 2001, Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: effect of polyglutamylation on MTX transport, Cancer Res., 61, 7225

Cited by

Sorted by citations

Metadata

Authors
Zaja, R., Caminada, D., Lončar, J., Fent, K., & Smital, T.
Venue
Toxicology and Applied Pharmacology
Publisher
Elsevier BV
Published
2008-03
Volume
227
Issue
2
Pages
207-218
ISSN
0041-008X
DOI
10.1016/j.taap.2007.11.001
Cited by
34
References
1
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review